Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 46 (4), 1160-1166
- https://doi.org/10.1038/ki.1994.380
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPDKidney International, 1994
- Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid functionKidney International, 1993
- The spectrum of bone disease in end-stage renal failure—An evolving disorderKidney International, 1993
- Pulse Oral Calcitriol for the Treatment of Hyperparathyroidism in Patients on Continuous Ambulatory Peritoneal Dialysis: Preliminary ObservationsAmerican Journal of Kidney Diseases, 1992
- Evolution of Secondary Hyperparathyroidism during Oral Calcitriol Therapy in Pediatric Renal OsteodystrophyPublished by S. Karger AG ,1990
- Oral and Parenteral Calcitriol for the Management of End-Stage Renal Disease1Published by S. Karger AG ,1990
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.JCI Insight, 1989
- Bone disease in pediatric patients undergoing dialysis with CAPD or CCPDKidney International, 1988
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.JCI Insight, 1984